New York is bucking the national trend in the largest category of health insurance costs, but in exactly the wrong way.
Per-recipient spending by New York's Medicaid program has long far exceeded the national norm, a telling symptom of inefficiency in the state's health plan for the poor. But the gap appears to have narrowed significantly during Governor Andrew Cuomo's term, with New York's spending rate falling at about twice the national average between 2010 and 2014.
Newly released Census Bureau data on the nation’s declining uninsured rate held good news and bad news for New York.
How is New York’s health insurance market weathering the Affordable Care Act crosswinds? Relatively well in some respects and poorly in others.
New York State's low-cost Essential Plan is taking a big bite out of the state's market for private health insurance, newly released data show.
By going along with double-digit premium hikes for individual-market health plans, the state is loosening handcuffs that should not exist.
New York’s hospitals collectively rank dead last among the 50 states in a new report card from the federal government, an Empire Center analysis shows.
Here’s a puzzling statistic: Recipients enrolled in Medicaid managed care plans use emergency rooms more often, not less, than those in the old-style “fee for service” program.
A study charges that Medicaid managed care plans are systematically denying care to elderly and disabled shut-ins. While the report raises concerns, its findings do not warrant abandoning an important reform effort.
New York emerged as the second-costliest state for employer-sponsored health insurance after its premiums rose at more than three times the national rate in 2015.
Why a single-payer health plan would be wrong for New York
Governor Cuomo’s deal with legislative leaders on expanded access to breast cancer screening falls squarely within three unfortunate Albany traditions: It micromanages the health-care industry in ways that add red tape and drive up costs. It singles out a high-profile disease for special treatment. And it accomplishes less than what’s promised by the press release.